SYVC

Synovics Pharmaceuticals, Inc. Stock Price

OTCPK:SYVC Community·US$3.6k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SYVC Share Price Performance

US$0.0001
0.00 (9,900.00%)
US$0.0001
0.00 (9,900.00%)
Price US$0.0001

SYVC Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Synovics Pharmaceuticals, Inc. Key Details

US$19.1m

Revenue

US$14.6m

Cost of Revenue

US$4.5m

Gross Profit

US$9.5m

Other Expenses

-US$5.0m

Earnings

Last Reported Earnings
Jul 31, 2009
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About SYVC

Founded
1983
Employees
n/a
CEO
Jyotindra Gange
Website
n/a

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.

Recent SYVC News & Updates

No updates

Recent updates

No updates